140 related articles for article (PubMed ID: 27146715)
21. Naltrexone Transport by a Proton-Coupled Organic Cation Antiporter in hCMEC/D3 Cells, an in Vitro Human Blood-Brain Barrier Model.
Kitamura A; Higuchi K; Kurosawa T; Okura T; Kubo Y; Deguchi Y
Biol Pharm Bull; 2022; 45(10):1585-1589. PubMed ID: 36184519
[TBL] [Abstract][Full Text] [Related]
22. A polyspecific drug/proton antiporter mediates diphenhydramine and clonidine transport at the mouse blood-retinal barrier.
Chapy H; André P; Declèves X; Scherrmann JM; Cisternino S
Br J Pharmacol; 2015 Oct; 172(19):4714-25. PubMed ID: 26177775
[TBL] [Abstract][Full Text] [Related]
23. Carrier-mediated cocaine transport at the blood-brain barrier as a putative mechanism in addiction liability.
Chapy H; Smirnova M; André P; Schlatter J; Chiadmi F; Couraud PO; Scherrmann JM; Declèves X; Cisternino S
Int J Neuropsychopharmacol; 2014 Oct; 18(1):. PubMed ID: 25539501
[TBL] [Abstract][Full Text] [Related]
24. Functional expression of a proton-coupled organic cation (H+/OC) antiporter in human brain capillary endothelial cell line hCMEC/D3, a human blood-brain barrier model.
Shimomura K; Okura T; Kato S; Couraud PO; Schermann JM; Terasaki T; Deguchi Y
Fluids Barriers CNS; 2013 Jan; 10(1):8. PubMed ID: 23351963
[TBL] [Abstract][Full Text] [Related]
25. Transport characteristics of tramadol in the blood-brain barrier.
Kitamura A; Higuchi K; Okura T; Deguchi Y
J Pharm Sci; 2014 Oct; 103(10):3335-41. PubMed ID: 25175482
[TBL] [Abstract][Full Text] [Related]
26. Structural Requirements for Uptake of Diphenhydramine Analogs into hCMEC/D3 Cells Via the Proton-Coupled Organic Cation Antiporter.
Tega Y; Tabata H; Kurosawa T; Kitamura A; Itagaki F; Oshitari T; Deguchi Y
J Pharm Sci; 2021 Jan; 110(1):397-403. PubMed ID: 32898521
[TBL] [Abstract][Full Text] [Related]
27. [Research progress of pyrilamine-sensitive H~+/OC antiporter].
Wang XY; Zhang ZR
Yao Xue Xue Bao; 2016 Jun; 51(6):886-91. PubMed ID: 29878742
[TBL] [Abstract][Full Text] [Related]
28. Imperatorin is Transported through Blood-Brain Barrier by Carrier-Mediated Transporters.
Tun T; Kang YS
Biomol Ther (Seoul); 2017 Jul; 25(4):441-451. PubMed ID: 28554202
[TBL] [Abstract][Full Text] [Related]
29. Cellular localization of the organic cation transporters, OCT1 and OCT2, in brain microvessel endothelial cells and its implication for MPTP transport across the blood-brain barrier and MPTP-induced dopaminergic toxicity in rodents.
Lin CJ; Tai Y; Huang MT; Tsai YF; Hsu HJ; Tzen KY; Liou HH
J Neurochem; 2010 Aug; 114(3):717-27. PubMed ID: 20477935
[TBL] [Abstract][Full Text] [Related]
30. Saturable distribution of tacrine into the striatal extracellular fluid of the rat: evidence of involvement of multiple organic cation transporters in the transport.
Sung JH; Yu KH; Park JS; Tsuruo T; Kim DD; Shim CK; Chung SJ
Drug Metab Dispos; 2005 Mar; 33(3):440-8. PubMed ID: 15547049
[TBL] [Abstract][Full Text] [Related]
31. Donepezil, tacrine and alpha-phenyl-n-tert-butyl nitrone (PBN) inhibit choline transport by conditionally immortalized rat brain capillary endothelial cell lines (TR-BBB).
Kang YS; Lee KE; Lee NY; Terasaki T
Arch Pharm Res; 2005 Apr; 28(4):443-50. PubMed ID: 15918518
[TBL] [Abstract][Full Text] [Related]
32. Involvement of carrier-mediated transport in the retinal uptake of clonidine at the inner blood-retinal barrier.
Kubo Y; Tsuchiyama A; Shimizu Y; Akanuma S; Hosoya K
Mol Pharm; 2014 Oct; 11(10):3747-53. PubMed ID: 25222277
[TBL] [Abstract][Full Text] [Related]
33. Blood-brain barrier transport of pramipexole, a dopamine D2 agonist.
Okura T; Ito R; Ishiguro N; Tamai I; Deguchi Y
Life Sci; 2007 Apr; 80(17):1564-71. PubMed ID: 17307202
[TBL] [Abstract][Full Text] [Related]
34. Proton-Coupled Organic Cation Antiporter Contributes to the Hepatic Uptake of Matrine.
Wu C; Sun X; Feng C; Liu X; Wang H; Feng F; Zhang J
J Pharm Sci; 2016 Mar; 105(3):1301-6. PubMed ID: 26886331
[TBL] [Abstract][Full Text] [Related]
35. The mystery of the human proton-organic cation antiporter: One transport protein or many?
Sachkova A; Jensen O; Dücker C; Ansari S; Brockmöller J
Pharmacol Ther; 2022 Nov; 239():108283. PubMed ID: 36162727
[TBL] [Abstract][Full Text] [Related]
36. Impact of Nicotine Transport across the Blood-Brain Barrier: Carrier-Mediated Transport of Nicotine and Interaction with Central Nervous System Drugs.
Tega Y; Yamazaki Y; Akanuma SI; Kubo Y; Hosoya KI
Biol Pharm Bull; 2018; 41(9):1330-1336. PubMed ID: 30175770
[TBL] [Abstract][Full Text] [Related]
37. How do psychostimulants enter the human brain? Analysis of the role of the proton-organic cation antiporter.
Sachkova A; Doetsch DA; Jensen O; Brockmöller J; Ansari S
Biochem Pharmacol; 2021 Oct; 192():114751. PubMed ID: 34464621
[TBL] [Abstract][Full Text] [Related]
38. Influx and efflux transport of H1-antagonist epinastine across the blood-brain barrier.
Ishiguro N; Nozawa T; Tsujihata A; Saito A; Kishimoto W; Yokoyama K; Yotsumoto T; Sakai K; Igarashi T; Tamai I
Drug Metab Dispos; 2004 May; 32(5):519-24. PubMed ID: 15100174
[TBL] [Abstract][Full Text] [Related]
39. A novel organic cation transporter involved in paeonol transport across the inner blood-retinal barrier and changes in uptake in high glucose conditions.
Gyawali A; Kim MH; Kang YS
Exp Eye Res; 2021 Jan; 202():108387. PubMed ID: 33301773
[TBL] [Abstract][Full Text] [Related]
40. Tetraethylammonium and amantadine identify distinct organic cation transporters in rat renal cortical proximal and distal tubules.
Goralski KB; Sitar DS
J Pharmacol Exp Ther; 1999 Jul; 290(1):295-302. PubMed ID: 10381790
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
